Skip Nav Destination
Issues
1 April 2018
ISSN 0022-1767
EISSN 1550-6606
In this Issue
IN THIS ISSUE
PILLARS OF IMMUNOLOGY
BRIEF REVIEWS
Development, Homeostasis, and Functions of Intestinal Intraepithelial Lymphocytes
J Immunol (2018) 200 (7): 2235–2244.
CUTTING EDGE
Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway Activation
Katalin Paréj; Andrea Kocsis; Csenge Enyingi; Ráhel Dani; Gábor Oroszlán; László Beinrohr; József Dobó; Péter Závodszky; Gábor Pál; Péter Gál
J Immunol (2018) 200 (7): 2247–2252.
ALLERGY AND OTHER HYPERSENSITIVITIES
Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease
J Immunol (2018) 200 (7): 2253–2262.
ANTIGEN RECOGNITION AND RESPONSES
Peptide–MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations
Cristina Rius; Meriem Attaf; Katie Tungatt; Valentina Bianchi; Mateusz Legut; Amandine Bovay; Marco Donia; Per thor Straten; Mark Peakman; Inge Marie Svane; Sascha Ott; Tom Connor; Barbara Szomolay; Garry Dolton; Andrew K. Sewell
J Immunol (2018) 200 (7): 2263–2279.
AUTOIMMUNITY
FHR5 Binds to Laminins, Uses Separate C3b and Surface-Binding Sites, and Activates Complement on Malondialdehyde-Acetaldehyde Surfaces
Ramona B. Rudnick; Qian Chen; Emma Diletta Stea; Andrea Hartmann; Nikolina Papac-Milicevic; Fermin Person; Michael Wiesener; Christoph J. Binder; Thorsten Wiech; Christine Skerka; Peter F. Zipfel
J Immunol (2018) 200 (7): 2280–2290.
CLINICAL AND HUMAN IMMUNOLOGY
Human Binge Alcohol Intake Inhibits TLR4–MyD88 and TLR4–TRIF Responses but Not the TLR3–TRIF Pathway: HspA1A and PP1 Play Selective Regulatory Roles
J Immunol (2018) 200 (7): 2291–2303.
The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo
Adam Palazzo; Sylvia Herter; Laura Grosmaire; Randy Jones; Christian R. Frey; Florian Limani; Marina Bacac; Pablo Umana; Robert J. Oldham; Michael J. E. Marshall; Kerry L. Cox; Anna H. Turaj; Mark S. Cragg; Christian Klein; Matthew J. Carter; Stacey Tannheimer
J Immunol (2018) 200 (7): 2304–2312.
IMMUNE REGULATION
Reciprocal Regulation of Glycolysis-Driven Th17 Pathogenicity and Regulatory T Cell Stability by Cdc42
J Immunol (2018) 200 (7): 2313–2326.
A Novel Biological Role for Peptidyl-Arginine Deiminases: Citrullination of Cathelicidin LL-37 Controls the Immunostimulatory Potential of Cell-Free DNA
Alicia Wong; Danuta Bryzek; Ewelina Dobosz; Carsten Scavenius; Pavel Svoboda; Maria Rapala-Kozik; Adam Lesner; Ivo Frydrych; Jan Enghild; Piotr Mydel; Jan Pohl; Paul R. Thompson; Jan Potempa; Joanna Koziel
J Immunol (2018) 200 (7): 2327–2340.
TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production
Jia Liu; Qing Yu; Weimin Wu; Xuan Huang; Ruth Broering; Melanie Werner; Michael Roggendorf; Dongliang Yang; Mengji Lu
J Immunol (2018) 200 (7): 2341–2351.
IMMUNE SYSTEM DEVELOPMENT
Bruton’s Tyrosine Kinase Is Not Essential for B Cell Survival beyond Early Developmental Stages
Lindsay E. Nyhoff; Emily S. Clark; Bridgette L. Barron; Rachel H. Bonami; Wasif N. Khan; Peggy L. Kendall
J Immunol (2018) 200 (7): 2352–2361.
IMMUNOGENETICS
HLA Class II–Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection
J Immunol (2018) 200 (7): 2372–2390.
INFECTIOUS DISEASE AND HOST RESPONSE
Septic Shock Shapes B Cell Response toward an Exhausted-like/Immunoregulatory Profile in Patients
Claude-Alexandre Gustave; Morgane Gossez; Julie Demaret; Thomas Rimmelé; Alain Lepape; Christophe Malcus; Françoise Poitevin-Later; Laurent Jallades; Julien Textoris; Guillaume Monneret; Fabienne Venet
J Immunol (2018) 200 (7): 2418–2425.
INNATE IMMUNITY AND INFLAMMATION
αMβ2 Is Antiatherogenic in Female but Not Male Mice
Dorota Szpak; Lahoucine Izem; Dmitriy Verbovetskiy; Dmitry A. Soloviev; Valentin P. Yakubenko; Elzbieta Pluskota
J Immunol (2018) 200 (7): 2426–2438.
MOLECULAR AND STRUCTURAL IMMUNOLOGY
c-Src–Dependent and –Independent Functions of Matk in Osteoclasts and Osteoblasts
J Immunol (2018) 200 (7): 2455–2463.
Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy
Amy J. Osborne; Matteo Breno; Nicolo Ghiringhelli Borsa; Fengxiao Bu; Véronique Frémeaux-Bacchi; Daniel P. Gale; Lambertus P. van den Heuvel; David Kavanagh; Marina Noris; Sheila Pinto; Pavithra M. Rallapalli; Giuseppe Remuzzi; Santiago Rodríguez de Cordoba; Angela Ruiz; Richard J. H. Smith; Paula Vieira-Martins; Elena Volokhina; Valerie Wilson; Timothy H. J. Goodship; Stephen J. Perkins
J Immunol (2018) 200 (7): 2464–2478.
TRANSPLANTATION
Blockade of Host β2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs
Hemn Mohammadpour; Rachel O’Neil; Jingxin Qiu; Philip L. McCarthy; Elizabeth A. Repasky; Xuefang Cao
J Immunol (2018) 200 (7): 2479–2488.
NOVEL IMMUNOLOGICAL METHODS
Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells
J Immunol (2018) 200 (7): 2489–2501.
CORRECTIONS
Correction: Green Tea Polyphenol EGCG Upregulates Tollip Expression by Suppressing Elf-1 Expression
Motofumi Kumazoe; Mai Yamashita; Yuki Nakamura; Kanako Takamatsu; Jaehoon Bae; Shuya Yamashita; Shuhei Yamada; Hiroaki Onda; Takashi Nojiri; Kenji Kangawa; Hirofumi Tachibana
J Immunol (2018) 200 (7): 2502–2504.
Correction: Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner
Liat Izhak; Gizi Wildbaum; Uri Weinberg; Yuval Shaked; Jennifer Alami; Daniel Dumont; Boris Friedman; Avi Stein; Nathan Karin
J Immunol (2018) 200 (7): 2509–2510.
-
Cover Image
Cover Image
On the cover: Deletion of nfkb2 in Foxp3+ regulatory T cells (Tregs) results in impaired Treg homeostasis, altered suppressive function, and systemic inflammation. However, concomitant ablation of relb in nfkb2-deleted Treg cells restores suppressive function and, as revealed here by histopathological analysis of colon sections, rescues the intestinal inflammation. Grinberg-Bleyer, Y., R. Caron, J. J. Seeley, N. S. De Silva, C. W. Schindler, M. S. Hayden, U. Klein, and S. Ghosh. 2018. The alternative NF-κB pathway in regulatory T cell homeostasis and suppressive function. J. Immunol. 200: 2362–2371.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement
Advertisement